D. Weiner

发表

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables

P. Watkins, J. Powell, Rachel Tyson, 2020, Frontiers in Pharmacology.

Cardiovascular Properties of a New Cardiotonic Agent: MDL 17,043 (1,3‐Dihydro-4‐methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol‐2-one)

C. P. Hsieh, D. Weiner, R. C. Dage, 1982, Journal of cardiovascular pharmacology.

Response to “Personalized Dosing = Approved Wide Dose Ranges + Dose Titration”

J. Powell, D. Weiner, Yaning Wang, 2020, Clinical pharmacology and therapeutics.

Serum Concentrations, Pharmacokinetic/Pharmacodynamic Modeling and Effects of Dexamethasone on Inflammatory Mediators following Intravenous and Oral Administration to Exercised Horses.

D. Weiner, P. Kass, R. Arthur, 2020, Drug testing and analysis.

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes

Stephen J. Balevic, M. Cohen-Wolkowiez, D. Weiner, 2022, Lupus Science & Medicine.

Bioavailability of medroxalol in man.

D. Weiner, R. Okerholm, F. Keeley, 1983, Biopharmaceutics & drug disposition.

Pharmacokinetic linearity of desipramine hydrochloride.

D. Weiner, D. Garteiz, R. Okerholm, 1981, Journal of pharmaceutical sciences.

Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.

H. Cheng, D. Weiner, J. M. Grisar, 1980, Life sciences.

Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients

T. Wiltshire, D. Mager, D. Weiner, 2021, Clinical and translational science.

Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications

Johan Gabrielsson, Daniel Weiner, D. Weiner, 2002 .

Non-compartmental analysis.

Johan Gabrielsson, D. Weiner, J. Gabrielsson, 2012, Methods in molecular biology.

Drug Dosing Recommendations for All Patients: A Roadmap for Change

J. Powell, D. Weiner, Yaning Wang, 2020, Clinical pharmacology and therapeutics.

Bioavailability of terfenadine in man.

D. Weiner, R. Hook, C. Cook, 1981, Biopharmaceutics & drug disposition.

Comprar Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, Fourth Edition | Johan Gabrielsson | 9789197651004 | Informa Healthcare

Johan Gabrielsson, D. Weiner, J. Gabrielsson, 2007 .

Pharmacokinetics and selected pharmacodynamics of morphine and its active metabolites in horses after intravenous administration of four doses.

D. Weiner, P. Kass, E. Steffey, 2019, Journal of veterinary pharmacology and therapeutics.

Leveraging a Previously Published Population Pharmacokinetic Model to Predict Rivaroxaban Exposure in Real‐World Patients

J. Powell, J. H. Patterson, D. Weiner, 2022, Journal of clinical pharmacology.

Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

P. Watkins, J. Powell, D. Weiner, 2020, Clinical and translational science.

Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID‐19 pandemic

T. Wiltshire, D. Weiner, D. Crona, 2021, Clinical and translational science.

Pharmacokinetics and pharmacodynamics of intra-articular isoflupredone following administration to horses with lipopolysaccharide-induced synovitis

D. Weiner, L. Harrison, H. Knych, 2022, BMC veterinary research.

Pattern Recognition in Pharmacokinetic Data Analysis

Johan Gabrielsson, Bernd Meibohm, Daniel Weiner, 2015, The AAPS Journal.

Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial

Stephen J. Balevic, M. Cohen-Wolkowiez, D. Weiner, 2022, Lupus Science & Medicine.

Pharmacokinetic and pharmacodynamic analyses of cocaine and its metabolites in behaviorally divergent inbred mouse strains

L. Tarantino, D. Weiner, W. Zamboni, 2020, Genes, brain, and behavior.

Correlation between inotropic activity and drug plasma levels of a new cardiotonic agent, MDL 19205

D. Weiner, J. K. Woodward, Richard A. Okerholm, 1985 .

Method of analysis of the new cardiotonic agent, MDL 19,205, in plasma and urine and its application in a dog pharmacokinetic study.

D. Weiner, D. Garteiz, J. Theile, 1983, Journal of Chromatography A.

Bioavailability of Terfenadine (Teldaner) in Man

D. Weiner, R. Hook, C. Cook, 1980 .

Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress‐Testing Renal Function Range in Real World Patients

J. Powell, D. Weiner, D. Gonzalez, 2023, Clinical pharmacology and therapeutics.

A Real‐World Evidence Framework for Optimizing Dosing in All Patients With COVID‐19

Daniel Weiner, Richard W Peck, Jack Cook, 2020, Clinical pharmacology and therapeutics.

Regarding Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012–2018

J. Powell, D. Weiner, J. Cook, 2020, Clinical pharmacology and therapeutics.

Methodology for pharmacokinetic/pharmacodynamic data analysis.

Weiner, Gabrielsson, D. Weiner, 1999, Pharmaceutical science & technology today.